Inhibitory action of ambocarb on voltage-operated sodium channels in rat isolated hippocampal pyramidal neurons

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 1-2, 2000, Pages 46-54

  Kopanitsa, Maksim V ^a   Krishtal, Oleg A ^a   Komissarov, Igor V ^b  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b DONETSK MEDICAL UNIVERSITY   (Ukraine)

Author keywords

carbolines; Ambocarb; Hippocampal; Ischaemia; Nootropic; Piracetam; Sodium channels; Sodium currents; Trauma

Indexed keywords

1 OXO 3,3,6 TRIMETHYL 1,2,3,4 TETRAHYDROINDOLO[2,3 C]QUINOLINE; 4 AMINOBUTYRIC ACID A RECEPTOR; AMBOCARB; BETA CARBOLINE DERIVATIVE; NEUROPROTECTIVE AGENT; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HYPERPOLARIZATION; NEUROPROTECTION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; SODIUM CURRENT;

ACTION POTENTIALS; ANIMALS; CELLS, CULTURED; HARMINE; HIPPOCAMPUS; NOOTROPIC AGENTS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; SODIUM CHANNELS;

EID: 0033950711     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03194.x     Document Type: Article

References (33)

1. Braestrup C, Nielsen M. Discovery of beta-carboline ligands for benzodiazepine receptors. Psychopharmacol. Ser. 1993; 11: 1-6.
2. Stephens DN, Schneider HH, Kehr W, Jensen LH, Petersen E, Honore T. Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: Relationship of pharmacological to biochemical measures of efficacy. Brain Res. Bull. 1987; 19: 309-18.
3. Kut'ko II, Sitchenko NM. The clinical efficacy of the Ukrainian preparation ambocarb. Lik. Sprava 1995; 9-12: 96-8 (in Russian).
4. Komissarov IV, Leshchinskaya EY. Psychopharmacotherapeutic potential of tetramethyleneharmanes and other modulators of glutamate receptors. Zh. Akad. Medychn. Nauk Ukrainy 1998; 4: 199-215 (in Russian with an English abstract).
5. + channels as targets for neuroprotective drugs. Trends. Pharmacol. Sci. 1995; 16: 309-16.
6. + channels: A rational and effective strategy against ischemic brain damage. Pharmacol. Rev. 1996; 48: 21-67.
7. Lakics V, Molnar P, Erdo SL. Protection against veratridine toxicity in rat cortical cultures: Relationship to sodium channel blockade. Neuroreport 1995; 7: 89-92.
8. + channels in rat cortical neurons. Eur. J. Pharmacol. 1995; 273: 303-6.
9. + conductances in rat neocortical neurons: Appearance of a slowly inactivating component. J. Neurophysiol. 1988; 59: 778-95.
10. Krishtal OA, Marchenko SM, Pidoplichko VI. Receptor for ATP in the membrane of mammalian sensory neurones. Neurosci. Lett. 1983; 35: 41-5.
11. Vreugdenhil M, Faas GC, Wadman WJ. Sodium currents in isolated rat CA1 neurons after kindling epileptogenesis. Neuroscience 1998; 86: 99-107.
12. Solntseva EI, Bukanova JV, Ostrovskaya RU, Gudasheva TA, Voronina TA, Skrehitsky VG. The effects of piracetam and its novel peptide analogue GVS-111 on neuronal voltage-gated calcium and potassium channels. Gen. Pharmacol. 1997; 29: 85-9.
13. Verbnyi Y, Derzhiruk LP, Mogilevskii AY. Piracetam-induced changes in the functional activity of neurons as a possible mechanism for the effects of nootropic agents. Neurosci. Behav. Physiol. 1996; 26: 507-15.
14. Bean BP, Cohen CJ, Tsien RW. Lidocaine block of cardiac sodium channels. J. Gen. Physiol. 1983; 81: 613-42.
15. Fischer HD, Wustmann C, Rudolph E, Zaytsev Y, Borodkin Y, Schmidt J. The antihypoxic effect of ethymisole: A comparison with other nootropic drugs. Biomed. Biochim. Acta 1989; 48: 843-7.
16. Lun A, Fischer HD, Wustmann C et al. Effects of piracetam on brain development in newborn rats exposed to hypoxia. Biomed. Biochim. Acta 1984; 43: 789-95.
17. Boiko SS, Vitskova GI, Zherdev VP. Pharmacokinetics of the nootropic drugs. Eksp. Klin. Farmakol. 1997; 60: 62-70 (in Russian).
18. + channels. Neuroscience 1996; 73: 951-62.
19. McGivern JG, Patmore L, Sheridan RD. Actions of the novel neuroprotective agent, lifarizine (RS-87476), on voltage-dependent sodium currents in the neuroblastoma cell line, N1E-115. Br. J. Pharmacol. 1995; 114: 1738-44.
20. Hille B. Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 1977; 69: 497-515.
21. + channels in rat hippocampal neurones. Pflügers Arch. 1995; 430: 437-46.
22. + currents: Quantitative distinction from phenytoin and possible therapeutic implications. Mol. Pharmacol. 1997; 51: 1077-83.
23. Hebert T, Drapeau P, Pradier L, Dunn RJ. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol. Pharmacol. 1994; 45: 1055-60.
24. + channels. Mol. Pharmacol. 1998; 54: 712-21.
25. Liu J, Lai ZF, Wang XD, Tokutomi N, Nishi K. Inhibition of sodium current by chloride channel blocker 4.4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS) in guinea pig cardiac ventricular cells. J. Cardiovasc. Pharmacol. 1998; 31: 558-67.
26. Komissarov IV. Investigation of the mechanisms of action of non-benzodiazepine anxiolytics. Sov. Med. Report G. Neuropharmacol. 1992; 2: 63-111.
27. Titievsky AV, Railoma O, Nieminen SA, Airaksinen MM. Influence of flumazenil on the learning-enhancing effect of ambocarb in rats. Pharmacol. Biochem. Behav. 1994; 47: 681-8.
28. Obrenovitch TP. The ischaemic penumbra: Twenty years on. Cerebrovasc. Brain Metab. Rev. 1995; 7: 297-323.
29. Crepel V, Hammond C, Krnjevic K, Chinestra P, Ben-Ari Y. Anoxia-induced LTP of isolated NMDA receptor-mediated synaptic responses. J. Neurophysiol. 1993; 69: 1774-8.
30. Tsintsadze T, Lozovaya N, Klishin A, Krishtal O. NMDA receptor-mediated synapses between CA1 neurones: Activation by ischaemia. Neuroreport 1996; 7: 2679-82.
31. Araki T, Kogure K, Nishioka K. Comparative neuroprotective effects of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus. Res. Exp. Med. 1990; 190: 19-23.
32. Rischke R, Krieglstein J. Protective effect of vinpocetine against brain damage caused by ischemia. Jpn. J. Pharmacol. 1991; 56: 349-56.
33. Sauer D, Rischke R, Beck T et al. Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sci. 1988; 43: 1733-9.